181 related articles for article (PubMed ID: 26589811)
1. Characterization of the Protective Role of Regulatory T Cells in Experimental Periapical Lesion Development and Their Chemoattraction Manipulation as a Therapeutic Tool.
Francisconi CF; Vieira AE; Biguetti CC; Glowacki AJ; Trombone AP; Letra A; Menezes Silva R; Sfeir CS; Little SR; Garlet GP
J Endod; 2016 Jan; 42(1):120-6. PubMed ID: 26589811
[TBL] [Abstract][Full Text] [Related]
2. Vasoactive Intestinal Peptide Immunoregulatory Role at the Periapex: Associative and Mechanistic Evidences from Human and Experimental Periapical Lesions.
de Campos Soriani Azevedo M; Garlet TP; Francisconi CF; Colavite PM; Tabanez AP; Melchiades JL; Favaro Trombone AP; Sfeir C; Little S; Silva RM; Garlet GP
J Endod; 2019 Oct; 45(10):1228-1236. PubMed ID: 31402064
[TBL] [Abstract][Full Text] [Related]
3. IL-4/CCL22/CCR4 axis controls regulatory T-cell migration that suppresses inflammatory bone loss in murine experimental periodontitis.
Araujo-Pires AC; Vieira AE; Francisconi CF; Biguetti CC; Glowacki A; Yoshizawa S; Campanelli AP; Trombone AP; Sfeir CS; Little SR; Garlet GP
J Bone Miner Res; 2015 Mar; 30(3):412-22. PubMed ID: 25264308
[TBL] [Abstract][Full Text] [Related]
4. RANKL Triggers Treg-Mediated Immunoregulation in Inflammatory Osteolysis.
Francisconi CF; Vieira AE; Azevedo MCS; Tabanez AP; Fonseca AC; Trombone APF; Letra A; Silva RM; Sfeir CS; Little SR; Garlet GP
J Dent Res; 2018 Jul; 97(8):917-927. PubMed ID: 29499125
[TBL] [Abstract][Full Text] [Related]
5. Distinctive Treg associated CCR4-CCL22 expression profile with altered frequency of Th17/Treg cell in the immunopathogenesis of Pemphigus Vulgaris.
Asothai R; Anand V; Das D; Antil PS; Khandpur S; Sharma VK; Sharma A
Immunobiology; 2015 Oct; 220(10):1129-35. PubMed ID: 26093920
[TBL] [Abstract][Full Text] [Related]
6. Imbalance of interleukin-17+ T-cell and Foxp3+ regulatory T-cell dynamics in rat periapical lesions.
Yang S; Zhu L; Xiao L; Shen Y; Wang L; Peng B; Haapasalo M
J Endod; 2014 Jan; 40(1):56-62. PubMed ID: 24331992
[TBL] [Abstract][Full Text] [Related]
7. Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs.
Kimpfler S; Sevko A; Ring S; Falk C; Osen W; Frank K; Kato M; Mahnke K; Schadendorf D; Umansky V
J Immunol; 2009 Nov; 183(10):6330-7. PubMed ID: 19841169
[TBL] [Abstract][Full Text] [Related]
8. Increase in activated Treg in TIL in lung cancer and in vitro depletion of Treg by ADCC using an antihuman CCR4 mAb (KM2760).
Kurose K; Ohue Y; Sato E; Yamauchi A; Eikawa S; Isobe M; Nishio Y; Uenaka A; Oka M; Nakayama E
J Thorac Oncol; 2015 Jan; 10(1):74-83. PubMed ID: 25325779
[TBL] [Abstract][Full Text] [Related]
9. Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus.
Lee HY; Hong YK; Yun HJ; Kim YM; Kim JR; Yoo WH
Rheumatology (Oxford); 2008 Jun; 47(6):789-94. PubMed ID: 18388146
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of regulatory T cells and proinflammatory cytokines in angiogenesis in the endometriotic milieu.
Wang XQ; Zhou WJ; Luo XZ; Tao Y; Li DJ
Hum Reprod; 2017 Jun; 32(6):1304-1317. PubMed ID: 28383711
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B.
Gao Y; You M; Fu J; Tian M; Zhong X; Du C; Hong Z; Zhu Z; Liu J; Markowitz GJ; Wang FS; Yang P
J Hepatol; 2022 Jan; 76(1):148-159. PubMed ID: 34689996
[TBL] [Abstract][Full Text] [Related]
12. A CCR4 antagonist enhances DC activation and homing to the regional lymph node and shows potent vaccine adjuvant activity through the inhibition of regulatory T-cell recruitment.
Yamamoto S; Matsuo K; Nagakubo D; Higashiyama S; Nishiwaki K; Oiso N; Kawada A; Yoshie O; Nakayama T
J Pharmacol Sci; 2018 Mar; 136(3):165-171. PubMed ID: 29519579
[TBL] [Abstract][Full Text] [Related]
13. Critical role of CCL22/CCR4 axis in the maintenance of immune homeostasis during apoptotic cell clearance by splenic CD8α(+) CD103(+) dendritic cells.
Hao S; Han X; Wang D; Yang Y; Li Q; Li X; Qiu CH
Immunology; 2016 Jun; 148(2):174-86. PubMed ID: 26868141
[TBL] [Abstract][Full Text] [Related]
14. Neem leaf glycoprotein inhibits CD4+CD25+Foxp3+ Tregs to restrict murine tumor growth.
Chakraborty T; Bose A; Barik S; Goswami KK; Banerjee S; Goswami S; Ghosh D; Roy S; Chakraborty K; Sarkar K; Baral R
Immunotherapy; 2011 Aug; 3(8):949-69. PubMed ID: 21843083
[TBL] [Abstract][Full Text] [Related]
15. Tumors establish resistance to immunotherapy by regulating T
Marshall LA; Marubayashi S; Jorapur A; Jacobson S; Zibinsky M; Robles O; Hu DX; Jackson JJ; Pookot D; Sanchez J; Brovarney M; Wadsworth A; Chian D; Wustrow D; Kassner PD; Cutler G; Wong B; Brockstedt DG; Talay O
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33243932
[TBL] [Abstract][Full Text] [Related]
16. T helper and T suppressor cell reversal during the development of induced rat periapical lesions.
Stashenko P; Yu SM
J Dent Res; 1989 May; 68(5):830-4. PubMed ID: 2523917
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblast-derived interleukin-1β activates protumor C-C motif chemokine ligand 22 signaling in head and neck cancer.
Huang YH; Chang CY; Kuo YZ; Fang WY; Kao HY; Tsai ST; Wu LW
Cancer Sci; 2019 Sep; 110(9):2783-2793. PubMed ID: 31325403
[TBL] [Abstract][Full Text] [Related]
18. Distinct conformations of the chemokine receptor CCR4 with implications for its targeting in allergy.
Viney JM; Andrew DP; Phillips RM; Meiser A; Patel P; Lennartz-Walker M; Cousins DJ; Barton NP; Hall DA; Pease JE
J Immunol; 2014 Apr; 192(7):3419-27. PubMed ID: 24563252
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of Th17-related cytokine expression in experimentally induced rat periapical lesions.
Wei S; Kawashima N; Suzuki N; Xu J; Takahashi S; Zhou M; Koizumi Y; Suda H
Aust Endod J; 2013 Dec; 39(3):164-70. PubMed ID: 24279666
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-positive pyothorax-associated lymphoma expresses CCL17 and CCL22 chemokines that attract CCR4-expressing regulatory T cells.
Higuchi T; Matsuo K; Hashida Y; Kitahata K; Ujihara T; Taniguchi A; Yoshie O; Nakayama T; Daibata M
Cancer Lett; 2019 Jul; 453():184-192. PubMed ID: 30953706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
